Q32 Bio
QTTB
QTTB
54 hedge funds and large institutions have $144M invested in Q32 Bio in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
15% more capital invested
Capital invested by funds: $126M → $144M (+$18.3M)
162.49% less ownership
Funds ownership: 230.04% → 67.55% (-162%)
Holders
54
Holding in Top 10
3
Calls
$5K
Puts
–
Top Buyers
| 1 | +$5.34M | |
| 2 | +$3.16M | |
| 3 | +$2.93M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.61M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.56M |
Top Sellers
| 1 | -$6.27M | |
| 2 | -$558K | |
| 3 | -$424K | |
| 4 |
EAM
Exome Asset Management
New York
|
-$380K |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$368K |